leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Spring 2014: Special Edition: Psychedelics and Education
 
Media > Recent and Archival
June 17, 2014

U.S. Veterans: 19th Subject Enrolled and Treated

On June 17, 2014, the 19th subject was treated in our ongoing study of MDMA-assisted psychotherapy in 24 U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. This subject was enrolled on June 12. Data from this study will be combined with data from our two completed and three other ongoing Phase 2 studies of MDMA-assisted psychotherapy for PTSD, and used to design future Phase 3 studies. This study is led by Principal Investigator Michael Mithoefer, M.D., and co-therapist Annie Mithoefer, B.S.N., in Charleston, South Carolina. Virgil Huston, an Iraq veteran who participated in the study, wrote to MAPS after he had completed treatment. He wrote: “As a patient who has a bit of survivor’s guilt since I know many others who need this treatment as badly as I did, I have trouble accepting 2021 as the earliest date this can become widely available. Maybe you guys are the realistic ones, but keeping this away from people until then just doesn’t pass the logic test.” Download the study protocol



Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.